Concepts (52)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Serotonin, 5-HT1B | 2 | 2011 | 8 | 0.430 |
Why?
|
| Prefrontal Cortex | 1 | 2011 | 150 | 0.310 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2011 | 160 | 0.300 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2008 | 49 | 0.280 |
Why?
|
| Reflex, Startle | 1 | 2008 | 32 | 0.280 |
Why?
|
| Fluoxetine | 1 | 2008 | 41 | 0.280 |
Why?
|
| Motor Activity | 1 | 2008 | 323 | 0.240 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 2 | 2011 | 3 | 0.160 |
Why?
|
| Indoles | 2 | 2011 | 303 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 1102 | 0.130 |
Why?
|
| Infusions, Intravenous | 1 | 1994 | 401 | 0.100 |
Why?
|
| Iodocyanopindolol | 1 | 2011 | 2 | 0.090 |
Why?
|
| Desipramine | 1 | 2011 | 9 | 0.090 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2011 | 11 | 0.090 |
Why?
|
| Clomipramine | 1 | 2011 | 3 | 0.090 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2011 | 7 | 0.090 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2011 | 14 | 0.090 |
Why?
|
| Isotopes | 1 | 2011 | 26 | 0.090 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2011 | 32 | 0.090 |
Why?
|
| Exploratory Behavior | 1 | 2011 | 48 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2011 | 239 | 0.080 |
Why?
|
| Acoustic Stimulation | 1 | 2011 | 130 | 0.080 |
Why?
|
| Swimming | 1 | 2011 | 64 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2011 | 112 | 0.080 |
Why?
|
| Neural Inhibition | 1 | 2011 | 105 | 0.080 |
Why?
|
| Serotonin 5-HT1 Receptor Antagonists | 1 | 2008 | 1 | 0.070 |
Why?
|
| Serotonin 5-HT1 Receptor Agonists | 1 | 2008 | 4 | 0.070 |
Why?
|
| Substantia Nigra | 1 | 2008 | 27 | 0.070 |
Why?
|
| Globus Pallidus | 1 | 2008 | 18 | 0.070 |
Why?
|
| Oxadiazoles | 1 | 2008 | 37 | 0.070 |
Why?
|
| Behavior, Animal | 1 | 2011 | 390 | 0.070 |
Why?
|
| Mice | 3 | 2011 | 12271 | 0.070 |
Why?
|
| Schizophrenia | 1 | 2011 | 531 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1914 | 0.070 |
Why?
|
| Piperazines | 1 | 2008 | 284 | 0.060 |
Why?
|
| Pyridines | 1 | 2008 | 303 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 2495 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2008 | 2122 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1229 | 0.050 |
Why?
|
| Time Factors | 1 | 2011 | 5412 | 0.050 |
Why?
|
| Animals | 3 | 2011 | 28157 | 0.050 |
Why?
|
| Female | 2 | 2011 | 48773 | 0.030 |
Why?
|
| Pediatric Nursing | 1 | 1994 | 7 | 0.030 |
Why?
|
| Equipment Design | 1 | 1994 | 416 | 0.020 |
Why?
|
| Endophenotypes | 1 | 2011 | 19 | 0.020 |
Why?
|
| Fear | 1 | 2011 | 88 | 0.020 |
Why?
|
| Anxiety | 1 | 2011 | 337 | 0.020 |
Why?
|
| Glucose | 1 | 2011 | 692 | 0.020 |
Why?
|
| Comorbidity | 1 | 2011 | 1007 | 0.020 |
Why?
|
| Child | 1 | 1994 | 7358 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 2465 | 0.010 |
Why?
|
| Humans | 1 | 1994 | 93611 | 0.000 |
Why?
|